Biotech Drug Spending Increases 21 Percent Even as Growth in Rx ... - Business Wire (press release)
April 24, 2007| Biotech Drug Spending Increases 21 Percent Even as Growth in Rx ... Business Wire (press release), CA - ... the patient’s medication therapy, have recently been proven effective to treat more common conditions such as cancer, hepatitis C, rheumatoid arthritis, ... |
Safety issues cloud Amgen's outlook - Los Angeles Times
April 24, 2007| Safety issues cloud Amgen's outlook Los Angeles Times, CA - Enbrel, a drug for rheumatoid arthritis and other autoimmune diseases, posted an 11% increase in sales to $730 million. Amgen's new colorectal cancer drug, ... |